Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 3/2002

01-12-2002

Increased False Negative Rates in Sentinel Lymph Node Biopsies in Patients with Multi-Focal Breast Cancer

Authors: Vahit Ozmen, Mahmut Muslumanoglu, Neslihan Cabioglu, Sitki Tuzlali, Ridvan Ilhan, Abdullah Igci, Mustafa Kecer, Yavuz Bozfakioglu, Temel Dagoglu

Published in: Breast Cancer Research and Treatment | Issue 3/2002

Login to get access
Metadata
Title
Increased False Negative Rates in Sentinel Lymph Node Biopsies in Patients with Multi-Focal Breast Cancer
Authors
Vahit Ozmen
Mahmut Muslumanoglu
Neslihan Cabioglu
Sitki Tuzlali
Ridvan Ilhan
Abdullah Igci
Mustafa Kecer
Yavuz Bozfakioglu
Temel Dagoglu
Publication date
01-12-2002
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 3/2002
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1020890921238

Other articles of this Issue 3/2002

Breast Cancer Research and Treatment 3/2002 Go to the issue

OriginalPaper

Episomally Mediated Overexpression of Wild-Type erbB-2 Transforms MCF-10A Breast Epithelial Cells

OriginalPaper

Age-Dependent Changes in Breast Cancer Hormone Receptors and Oxidant Stress Markers

OriginalPaper

Mucinous Cancers have Fewer Genomic Alterations than More Common Classes of Breast Cancer

OriginalPaper

Expression of MUCI Splice Variants Correlates with Invasive Growth of Breast Cancer Cell Lines

OriginalPaper

Satisfaction and Anxiety for Women During Investigation of an Abnormal Screening Mammogram

Subject Index

Subject Index, Volume 76
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits